Metabolism Clinical Trial
Official title:
Influence of Age and Sex on Alcohol Metabolism and Acute Responses
This study will examine age and sex differences in alcohol metabolism and the effects of
alcohol. Men and women differ in their ability to metabolize alcohol, possibly due to
differences between men and women in lean body mass, liver size, or the activity of enzymes
that act on alcohol in the liver. Also, older men and women are thought to be more sensitive
to alcohol, although the reasons for this are not clear.
Healthy men and women between 21 and 25 years of age and between 55 and 65 years of age who
are social drinkers may be eligible for this study. Candidates will be screened with
questionnaires about their general and mental health, alcohol use, and family history of
alcohol use and problems. They will have a physical examination, electrocardiogram (EKG),
routine blood tests, urinalysis to test for drugs of abuse, and a blood test to study the
gene responsible for enzymes that metabolize alcohol. Younger women will have a urine
pregnancy test and older women will have a test to confirm post-menopausal status.
Participants will have two study sessions at the NIH Clinical Center outpatient clinic. They
come to the clinic by taxi and, upon arrival, take a breathalyzer test for any measurable
alcohol levels. They are then given breakfast, after which two catheters (plastic tubes) are
placed, one in a vein in each arm. One tube is used to collect blood samples for measuring
hormone levels; the other is for infusing alcohol. The infusion is adjusted so that the
breath alcohol level is held constant for about 3 hours at a moderate level. Baseline
measurements are taken before the infusion begins. During and after the infusion, the
participants fill out questionnaires about their moods and feelings. Breath alcohol level and
heart rate measurements are monitored frequently. After the test, participants remain in the
clinic until their breath alcohol level drops below 0.02 g/L (generally 2 to 3 hours after
the infusion stops). They are given lunch and then sent home in a taxi.
Participants also undergo a dual energy x-ray absorptiometry (DEXA) scan to determine lean
body mass and a magnetic resonance imaging (MRI) scan of the abdomen to determine liver size.
For the DEXA scan, the subject lies still on a table for about 30 minutes while the whole
body is scanned using a small amount of radiation. For the MRI, the subject lies in a narrow
metal cylinder (the scanner) about 30 minutes for the scan.
Previous studies, including our studies using the alcohol clamp, have shown that alcohol
pharmacokinetics differ between women and men. Some of the factors that may contribute to
these sex differences in absorption, distribution and metabolism include variation in lean
body mass (and total body water), liver size and differences in activity or capacity of
alcohol metabolizing enzymes in the stomach and livers of women and men. A fundamental
difference between men and women is in the levels of the sex hormones estrogen and
testosterone, which can influence several of the above factors. Sex differences in alcohol
pharmacokinetics, and estrogen itself, have been postulated as determinants of the increased
susceptibility of women to alcohol-related liver disease. An additional area of interest is
sex- and age-related differences in sensitivity to the effects of alcohol. The elderly are
thought to be more sensitive to alcohol and show greater impairment than younger individuals.
However, it is not clear if these changes are due to pharmacokinetic or pharmacodynamic
factors.
The objectives of this project are (I) to evaluate the influence of age and sex on alcohol
elimination rates in men and women, and (II) to determine the influence of age and sex on the
initial response and acute adaptation to alcohol on measures of subjective perceptions of
alcohol effects and heart rate. This study will be conducted in 24 young and 24 older
participants, with equal numbers of males and females in each group. Comparison of alcohol
elimination rates across these groups and correlation with liver volume and sex steroid
levels will provide a means to examine the influence of sex hormones, estrogen and
testosterone, in age-related and sex-related differences in alcohol metabolism and liver
volume. This study will examine age- and sex- related differences in response to alcohol on
subjective measures of intoxication and mood, as well as on heart-rate and
psychophysiological responses to emotional visual stimuli (pictures). This study will also
evaluate the effect of acute alcohol administration on gene expression in peripheral blood
cells. Findings from these studies will provide important new data regarding the role of sex
steroids (estrogen and testosterone) on the metabolism of alcohol, and a better understanding
of age- and sex-related differences in metabolic processes that may underlie medically
important differences in the responses of individuals to alcohol.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05488574 -
Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss
|
N/A | |
Recruiting |
NCT05582824 -
Lactate Metabolism in the Hypoperfused Critically Ill
|
||
Recruiting |
NCT05443347 -
Activity, Adiposity, and Appetite in Adolescents 2 Intervention
|
N/A | |
Completed |
NCT05020808 -
The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise
|
N/A | |
Recruiting |
NCT06082726 -
The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers
|
N/A | |
Completed |
NCT04144426 -
Meal Schedule Effects on Circadian Energy Balance in Adults
|
N/A | |
Completed |
NCT03424395 -
Personalized Dietary Program and Markers of Wellness
|
N/A | |
Completed |
NCT02441296 -
Carbohydrate and Metabolism: a Pilot Study
|
N/A | |
Completed |
NCT00176085 -
Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH
|
Phase 1 | |
Completed |
NCT00245986 -
Effect of Genetics on Metabolism of Efavirenz
|
Phase 4 | |
Completed |
NCT04025346 -
To Evaluate the Efficacy of Capsimax on Metabolic Rate
|
N/A | |
Completed |
NCT04078646 -
Influence of Proteins on the Bioavailability of Carotenoids
|
N/A | |
Active, not recruiting |
NCT06033898 -
Inactivity Duration on Lipid Metabolism
|
N/A | |
Active, not recruiting |
NCT06250270 -
Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning
|
Early Phase 1 | |
Completed |
NCT06285578 -
Effects of Probiotic and HIIT in Obese Women
|
N/A | |
Completed |
NCT04255368 -
Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response
|
N/A | |
Recruiting |
NCT06360796 -
Study of Pharmacokinetics and Metabolism on [(14)C]ADC189
|
Phase 1 | |
Recruiting |
NCT02005003 -
Cognitive and Metabolic Effects of a Probiotic Supplement
|
N/A | |
Completed |
NCT03146728 -
Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia
|
N/A | |
Completed |
NCT00692510 -
Drug Interaction Study Between AZD3480 and Cytochrome P450
|
Phase 1 |